These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 31412144)

  • 1. Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
    Nagai K; Uranbileg B; Chen Z; Fujioka A; Yamazaki T; Matsumoto Y; Tsukamoto H; Ikeda H; Yatomi Y; Chiba H; Hui SP; Nakazawa T; Saito R; Koshiba S; Aoki J; Saigusa D; Tomioka Y
    Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1(Suppl 1):e8551. PubMed ID: 31412144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
    Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
    J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.
    Cao H; Huang H; Xu W; Chen D; Yu J; Li J; Li L
    Anal Chim Acta; 2011 Apr; 691(1-2):68-75. PubMed ID: 21458633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
    Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
    Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.
    Liu SY; Zhang RL; Kang H; Fan ZJ; Du Z
    World J Gastroenterol; 2013 Jun; 19(22):3423-32. PubMed ID: 23801834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocarcinoma Discrimination by Ratiometric Lipid Profiles Using Tip-Contact Sampling/Ionization Mass Spectrometry.
    Chen X; Gao J; Wang T; Jiang X; Chen J; Liang X; Wu J
    Anal Chem; 2019 Aug; 91(16):10376-10380. PubMed ID: 31356056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches.
    Zhu J; Warner E; Parikh ND; Lubman DM
    Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.
    Ferrarini A; Di Poto C; He S; Tu C; Varghese RS; Kara Balla A; Jayatilake M; Li Z; Ghaffari K; Fan Z; Sherif ZA; Kumar D; Kroemer A; Tadesse MG; Ressom HW
    J Proteome Res; 2019 Aug; 18(8):3067-3076. PubMed ID: 31188000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry imaging of diclofenac and its metabolites in tissues using nanospray desorption electrospray ionization.
    Mesa Sanchez D; Brown HM; Yin R; Chen B; Vavrek M; Cancilla MT; Zhong W; Shyong B; Zhang NR; Li F; Laskin J
    Anal Chim Acta; 2022 Nov; 1233():340490. PubMed ID: 36283780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial metabolomics method to reveal differential metabolomes in microregions of Panax quinquefolius roots by using ultra-performance liquid chromatography quadrupole/time of flight-mass spectrometry and desorption electrospray ionization mass spectrometry imaging.
    Luo S; Yang X; Zhang Y; Kuang T; Tang C
    Food Chem; 2024 Mar; 435():137504. PubMed ID: 37813026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis.
    Tan Y; Yin P; Tang L; Xing W; Huang Q; Cao D; Zhao X; Wang W; Lu X; Xu Z; Wang H; Xu G
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.010694. PubMed ID: 22084000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.
    Schlichtemeier SM; Nahm CB; Xue A; Gill AJ; Smith RC; Hugh TJ
    J Surg Res; 2019 Jun; 238():127-136. PubMed ID: 30771682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
    Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
    Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive high-resolution mass spectrometry approach for characterization of metabolites by combination of ambient ionization, chromatography and imaging methods.
    Berisha A; Dold S; Guenther S; Desbenoit N; Takats Z; Spengler B; Römpp A
    Rapid Commun Mass Spectrom; 2014 Aug; 28(16):1779-91. PubMed ID: 25559448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.
    Alfaro CM; Jarmusch AK; Pirro V; Kerian KS; Masterson TA; Cheng L; Cooks RG
    Anal Bioanal Chem; 2016 Aug; 408(20):5407-14. PubMed ID: 27206411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach.
    Liang Q; Liu H; Wang C; Li B
    Sci Rep; 2016 Jan; 6():19763. PubMed ID: 26805550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced capabilities for imaging gangliosides in murine brain with matrix-assisted laser desorption/ionization and desorption electrospray ionization mass spectrometry coupled to ion mobility separation.
    Škrášková K; Claude E; Jones EA; Towers M; Ellis SR; Heeren RM
    Methods; 2016 Jul; 104():69-78. PubMed ID: 26922843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
    Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
    Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
    Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
    Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Profiling and Holistic Comparison of the Metabolomes among the Flower Buds of
    Jia L; Zuo T; Zhang C; Li W; Wang H; Hu Y; Wang X; Qian Y; Yang W; Yu H
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31212627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.